Atom Investors LP Abb Vie Inc. Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $2.03 Million - $2.52 Million	-15,389 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.65 Million - $2.09 Million	15,389 New	15,389 $2.08 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $2.62 Million - $3.08 Million	-30,542 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.24 Million - $3 Million	30,542 New	30,542 $3 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $5.44 Million - $8.24 Million	-84,293 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $6.35 Million - $7.94 Million	-87,982 Reduced 51.07%	84,293 $7.46 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $10.8 Million - $13 Million	172,275 New	172,275 $13 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.